---
title: 'Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A
  Nonrandomized Controlled Trial'
date: '2024-04-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38587854/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240408180554&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS AND RELEVANCE: This nonrandomized controlled trial demonstrated
  effectiveness of newborn screening for infants with SMA in the real-world setting.
  Functional outcomes and thus the response to treatment were significantly better
  in the newborn screening cohort compared to the unscreened clinical symptom onset
  ...'
disable_comments: true
---
CONCLUSIONS AND RELEVANCE: This nonrandomized controlled trial demonstrated effectiveness of newborn screening for infants with SMA in the real-world setting. Functional outcomes and thus the response to treatment were significantly better in the newborn screening cohort compared to the unscreened clinical symptom onset ...